_20090817231208.jpg)
Sector Snap: Obesity drugmakers rise on study
July 15th, 2010
| Tags: arena-pharmaceuticals, diet-drugs, juvederm, lorcaserin, qnexa, read-more-raquo, weight-loss-drugs
Shares of obesity drug developers rose Thursday following a report that Arena Pharmaceuticals Inc.’s lorcaserin prompted weight loss without heart-related side effects.On Wednesday, a study showed that lorcaserin caused more people to lose at least 5 percent of their body weight over one year, or more than double the rate of placebo.
Continued here:
Sector Snap: Obesity drugmakers rise on study
Leave a comment
| Trackback
